Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Lord Kamall on 23 June 2022 (HL731), whether they will publish the observational data on treatment outcomes referred to in the Answer.

NHS England continues to work closely with the research community, and relies on the expert and impartial analysis, and publication, of treatment outcome data by specialist study teams who will be better placed to consider potentially confounding factors and draw potential conclusions from the data. It has no plans to undertake its own study to separately analyse and report treatment outcomes data.

The PANORAMIC trial team has published the results of its molnupirivir arm, Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platformadaptive randomised controlled trial. A copy of this document is attached.

The trial remains open and is currently studying a second oral antiviral treatment, Paxlovid (nirmatrelvir+ritonavir.), in the same population.